Occurrence of ras mutations in human lung cancer

Neoplasma

Volumn 44, Issue 3, 1997, Pages 145-149

  Vachtenheim, J ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

K ras; lung cancer; mutation

Indexed keywords

GENE MUTATION; HUMAN; LUNG CANCER; ONCOGENE K RAS; REVIEW;

EID: 0030751333     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. BONFIL, R.D., REDDEL, R.R., URA, H., REICH, R., FRIDMAN, R., HARRIS, C.C., KLEIN-SZANTO, A.J.P.: Invasive and metastatic potential of a v-Ha-ras-transformed human bronchial epithelial cell line. J. Natl. Cancer Inst., 81, 1989, 587-594.
2. Bos, J.L.: Ras oncogenes in human cancer. A review. Cancer Res., 49, 1989, 4682-4689.
3. CAPELLA, G., CRONAUER-MITRA, S., PEINADO, M.A., PERUCHO, M.: Frequency and spectrum of mutations at codons 12 and 13 of the C-K-ras gene in human tumors. Environ. Health Persp., 93, 1991, 125-131.
4. CLEMENTS, N.C., JR., NELSON, M.A., WYMER, J.A., SAVAGE, C., AGUIRRE, M., GAREWAL, H.: Analysis of K-ras gene mutations in malignant and nonmalignant endobronchial tissue obtained by fiberoptic bronchoscopy. Am. J. Respir. Crit. Care Med., 152, 1995, 1374-1378.
5. GEORGES, R.N., MUKHOPADHYAY, T., ZHANG, Y.J., YEN, N., ROTH, J.A.: Prevention of orthotopic human lung cancer growth by intratracheal instillation of a retroviral antisense K-ras construct Cancer Res., 53, 1993, 1743-1746.
6. HUSGAFVEL-PURSIAINEN, K., RIDANPAA, M., HACKMAN, P., ANTTILA, S., KARJALAINEN, A., ONFELT, A., BORRESEN, A.L., VAINIO, H.: Detection of ras gene mutations in human lung cancer: Comparison of two screening assays based on the polymerase chain reaction. Environ. Health Persp., 98, 1992, 183-185.
7. HUSGAFVEL-PURSIAINEN, K., HACKMAN, P., RIDANPAA, M., ANTTILA, S., KARJALAINEN, A., PARTANEN, T., TAIKINA-AHO, O., HEIKKILA, L., VAINIO, H.: K-ras mutations in human adenocarcinoma of the lung: Association with smoking and occupational exposure to asbestos. Int. J. Cancer, 53, 1993, 250-256.
8. JACOBSON, D.R., FISHMAN, C.L., MILLS, N.E.: Molecular genetic tumor markers in the early diagnosis and screening of non-small-cell lung cancer. Ann. Oncol., Suppl. 3, 6, 1995, S3-S8.
9. KALEMKERIAN, G.P., JASTI, R.K., CELANO, P., NELKIN, B.D., MABRY, M.: All-trans-retinoic acid alters myc gene expression and inhibits in vitro progression in small cell lung cancer. Cell Growth Differ., 5, 1994, 55-60.
10. KERN, J.A., SLEBOS, R.J., TOP, B., RODENHUIS, S., LAGER, D., ROBINSON, R.A. WEINER, D., SCHWARTZ, D.A.: C-erbB-2 expression and codon 12 K-ras mutation both redict shortened survival for patients with pulmonary adenocarcinomas. J. Clin. Invest., 93, 1994, 516-520.
11. KOBAYASHI, T., TSUDA, H., NOGUCHI, M., HIROHASHI, S., SHIMOSATO, Y., GOYA, T., HAYATA, Y.: Association of point mutation in c-Ki-ras oncogene in lung adenocarcinomas with particular reference to cytologic subtypes. Cancer, 66, 1990, 289-294.
12. LEHMAN, T.A., SCOTT, F., SEDDON, M., KELLY, K., DEMPSEY, E.C., WILSON, V.L., MULSHINE, J.L., MODALI, R.: Detection of K-ras oncogene mutations by polymerase chain rection-based ligase chain reaction. Anal. Biochem., 239, 1996, 153-159.
13. LI, Z.H., ZHENG, J., WEISS, L.M., SHIBATA, D.: c-K-ras and p53 mutations occur very early in adenocarcinoma of the lung. Am. J. Pathol., 144, 1994, 303-309.
14. MABRY, M., NAKAGAWA, T., NELKIN, B.D., MCDOWELL, E., GESELL, M., EGGLESTON, J.C., CASERO, R.A., BAYLIN, S.B.: v-Ha-ras oncogene insertion: A model for tumor progression of human small cell lung cancer. Proc. Natl. Acad. Sci. USA, 85, 1988, 6523-6527.
15. MAO, L., HRUBAN, R.H., BOYLE, J.O., TOCKMAN, M., SIDRANSKY, D.: Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. Cancer Res.,54, 1994, 634-637.
16. MARCHETTI, A., BUTTITTA, F., PELLEGRINI, S., CHELLA, A., BERTACCA, G., FILARDO, A., TOGNONI, V., FERRELI, F., SIGNORINI, E., ANGELETTI, C.A., BEVILACQUA, G.: Bronchioloalveolar lung carcinomas: K-ras mutations are constant events in the mucinous subtype. J. Pathol., 179, 1996, 254-259.
17. MILLS, N.E., FISHMAN, C.L., SCHOLES, J., ANDERSON, S.E., ROM, W.N., JACOBSON, D.R.: Detection of K-ras oncogene mutations in bronchoalveolar lavage fluid for lung cancer diagnosis. J. Natl. Cancer Inst., 87, 1995, 1056-1060.
18. MILLS, N.E., FISHMAN, C.L., ROM, W.N., DUBIN, N., JACOBSON, D.R.: Increased prevalence of K-ras oncogene mutations in lung adenocarcinoma. Cancer Res., 55, 1995, 1444-1447.
19. MITSUDOMI, T., STEINBERG, S.M., OIE, H.K., MULSHINE, J.L., PHELPS, R., VIALLET, J., PASS, H., MINNA, J.D., GAZDAR, A.F.: Ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intent. Cancer Res., 51, 1991, 4999-5002.
20. MITSUDOMI, T., VIALLET, J., MULSHINE, J.L., LINNOILA, I., MINNA, J.D., GAZDAR, A.F.: Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines. Oncogene, 6, 1991, 1353-1362.
21. MUKHOPADHYAY, T., TAINSKY, M., CAVENDER, A.C., ROTH, J.A.: Specific inhibition of K-ras expression and tumorigenicity of lung cancer cells by antisense RNA. Cancer Res., 51, 1991, 1744-1748.
22. NELSON, M.A., WYMER, J., CLEMETS, N., Jr.: Detection of K-ras gene mutations in non-neoplastic lung tissue and lung cancers. Cancer Lett., 103, 1996, 115-121.
23. NEVILLE, E.M., ELLISON, G., KIARIS, H., STEWARD, M., SPANDIDOS, D.A., Fox, J.C., FIELD, J.K.: Detection of K-ras mutations in non-small cell lung carcinoma. Int. J. Oncol., 7, 1995, 511-514.
24. NOUTSOU, A., KOFFA, M., ERGAZAKI, M., SIAFAKAS, N.M., SPANDIDOS, D.A.: Detection of human papiloma virus (HPV) and K-ras mutations in human lung carcinomas. Int. J. Oncol., 8, 1996, 1089-1093.
25. OHSHIMA, S., SHIMIZU, Y., TAKAHAMA, M.: Detection of c-Ki-ras gene mutation in paraffin sections of adenocarcinoma and atypical bronchioloalveolar cell hyperplasia of human lung. Virchows Arch., 424, 1994, 129-134.
26. REYNOLDS, S.H., ANDERSON, M.W.: Activation of proto-oncogenes in human and mouse lung tumors. Env. Health Persp., 93, 1991, 145-148.
27. REYNOLDS, S.H., ANNA, C.K., BROWN, K.C., WIEST, J.S., BEATTIE, E.J., PERO, R.W., IGLEHART, D., ANDERSON, M.W.: Activated protooncogenes in human lung tumors from smokers. Proc. Natl. Acad. Sci. USA, 88, 1991, 1085-1089.
28. RIDANPAA, M., KARJALAINEN, A., ANTTILA, S., VAINIO, H., HUSGAFVEL-PURSIANEN, K.: Genetic alterations in p53 and K-ras in lung cancer in relation to histopathology of the tumor and smoking history of the patient. Int. J. Oncol., 5, 1994, 1109-1117.
29. RODENHUIS, S., VAN DE WETERING, M.L., MOOI, W.J., EVERS, S.G., VAN ZANDWIJK, N., BOS, J.L.: Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung. N. Engl. J. Med., 317, 1987, 929-935.
30. RODENHUIS, S., SLEBOS, R.J.C., BOOT, A.J.M., EVERS, S.G., MOOI, W.J., WAGENAAR, S.S., VAN BODEGOM, P.C., Bos, J.L.: Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the lung. Cancer Res., 48, 1988, 5738-5741.
31. RODENHUIS, S., SLEBOS, R.J.C.: The ras oncogenes in human lung cancer. Am. Rev. Respir. Dis., 142, 1990, S27-S30.
32. RODENHUIS, S., SLEBOS, R.J.C.: Clinical significance of ras oncogene activation in human lung cancer. Cancer Res., Suppl. 9, 52, 1992, 2665-2669.
33. ROSELL, R., LI, S., SKACEL, Z., MATE, J.L., MAESTRE, J., CANELA, M., TOLOSA, E., ARMENGOL, P., BARNADAS, A., ARIZA, A.: Prognostic impact of mutated K-ras gene in surgically resected non-small cell lung cancer patients. Oncogen, 8, 1993, 2407-2412.
34. SAITOH, A., KIMURA, M., TAKAHASHI, R., YOKOYAMA, M., NOMURA, T., IZAWA, M., SEKIYA, T., NISHIMURA, S., KATSUKI, M.: Most tumors in transgenic mice with human c-Ha-ras gene contained somatically activated transgenes. Oncogene, 5, 1990, 1195-1200.
35. SANTOS, E., MARTIN-ZANCA, D., REDDY, E.P., PIEROTTI, M.A., DELLA PORTA, G., BARBACID, M.: Malignant activation of a K-ras oncogene in lung carcinoma but not in normal tissue of the same patient. Science, 223, 1984, 661-664.
36. SHIBATA, D., SCHAEFFER, J., LI, Z.H., CAPELLA, G., PERUCHO, M.: Genetic heterogeneity of the c-K-ras locus in colorectal adenomas but not in adenocarcinomas. J. Natl. Cancer Inst., 85, 1993, 1058-1063.
37. SILINI, E.M., BOSI, F., PELLEGATA, N.S., VOLPATO, G., ROMANO, A., NAZARI, S., TINELLI, C., RANZANI, G.N., SOLCIA, E., FIOCCA, R.: K-ras gene mutations: An unfavorable prognostic marker in stage I lung adenocarcinoma. Virchows Arch. Int. J. Pathol., 424, 1994, 367-373.
38. SLEBOS, R.J.C., KIBBELAAR, R.E., DALESIO, O., KOOISTRA, A., STAM, J., MEIJER, C.J.L.M., WAGENAAR, S.S., VANDERSCHUEREN, R.G.J.R.A., VAN ZANDWIJK, N., MOOI, W.J., BOS, J.L., RODENHUIS, S.: K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N. Engl. J. Med., 323, 1990, 561-565.
39. SLEBOS, R.J.C., HRUBAN, R.H., DALESIO, O., MOOI, W.J., OFFERHAUS, G.J.A., RODENHUIS, S.: Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung. J. Natl. Cancer Inst., 83, 1991, 1024-1027.
40. SOZZI, G., Miozzo, M., PASTORIO, U, PILOTTI, S., DONGHI, R., GIAROLA, M., DEGREGORIO, L., MANENTI, G., RADICE, P., MINOLETTI, F., DELLAPORTA, G., PIEROTTI, M.A.: Genetic evidence for an independent origin of multiple preneoplastic and neoplastic lung lesions. Cancer Res., 55, 1995, 135-140.
41. SUDA, Y., AIZAWA, S., HIRAI, S., INOUE, T., FURUTA, Y., SUZUKI, M., HIROHASHI, S., IKAWA, Y: Driven by the same Ig enhancer and SV40 T promoter ras induced lung adenomatous tumors, myc induced pre-B lymphomas and SV40 large T gene a variety of tumors in transgenic mice. EMBO J., 6, 1987, 4055-4065.
42. SUGIO, K., ISHIDA, T., YOKOYAMA, H., INOUE, T., SUGIMACHI, K., SASAZUKI, T.: Ras gene mutations as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis. Cancer Res., 52, 1992, 2903-2906.
43. SUGIO, K., KISHIMOTO, Y., VIRMANI, A.K., HUNG, J. Y., GAZDAR, A.F.: K-ras mutations are a relatively late event in the pathogenesis of lung carcinomas.Cancer Res., 54, 1994, 5811-5815.
44. SUZUKI, Y., ORITA, M., SHIRAISHI, M., HAYASHI, K., SEKIYA, T.L.: Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene, 5, 1990, 1037-1043.
45. SZABO, E., BIRRER, M.J., MULSHINE, J.L.: Early detection of lung cancer. Semin. Oncol., 20, 1993, 374-382.
46. TAKEDA, s., ICHII, S., NAKAMURA, Y.: Detection of K-ras mutation in sputum by mutant-allele-specific amplification (MASA). Hum. Mutat., 2, 1993, 112-117.
47. TSUCHIYA, E., FURUTA, R., WADA, N., NAKAGAWA, K., ISHIKAWA, Y., AWABUCHI, B., NAKAMURA, Y., SUGANO, H.: High K-ras mutations rates in goblet-cell-type adenocarcinomas of the lungs. J. Cancer Res. Clin. Oncol., 121, 1995, 577-581.
48. URBAN, T., RICCI, S., LACAVE, R., ANTOINE, M., KAMBOUCHNER, M., CAPRON, R., BERNAUDIN, J.F.: Codon 12 Ki-ras mutations in non-small-cell lung cancer: Comparative evaluation of tumoural and non-tumoural lung. Br. J. Cancer, 74, 1996, 1051-1055.
49. VACHTENHEIM, J., HORÁKOVÁ, I., NOVOTNÁ, H., OPÁLKA, P., ROUBKOVÁ, H.: Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung. Clin. Cancer Res., 1, 1995, 359-365.
50. VAINIO, H., HUSGAFVEL-PURSIAINEN, K., ANTTILA, S., KARJALAINEN, A., HACKMAN, P., PARTANEN, T: Interaction between smoking and asbestos in human lung adenocarcinoma. Role of K-ras mutations. Env. Health Persp., Suppl. 3, 101, 1994, 189-192.
51. VIALETT, J., MINNA, J.D.: Dominant oncogenes and tumor suppressor genes in the pathogenesis of lung cancer. Am. J. Resp. Cell Mol. Biol., 2, 1990, 225-232.
52. WAGNER, S.N., MULLER, R., BOEHM, J., PUTZ, B., WUNSCH, P.H., HOFLER, H.: Neuroendocrine neoplasms of the lung are not associated with point mutations at codon 12 of the Ki-ras gene. Virchows Arch. B, Cell Pathol., 63, 1993, 325-329.
53. WESTRA, W.H., SLEBOS, R.J.C., OFFERHAUS, G.J.A., GOODMAN, S.N., EVERS, S.G., KENSLER, T.W., ASKIN, F.B., RODENHUIS, S., HRUBAN, R.H.: K-ras oncogene activation in lung adenocarcinomas from former smokers. Cancer, 72, 1993, 432-438.
54. YAKUBOVSKAYA, M.S., SPIEGELMAN, V., LUO, F.C., MALAEV, S., SALNEV, A., ZBOROVSKAYA, I., GASPARYAN, A., POLOTSKY, B., MACHALADZE, Z., TRACHTENBERG, A.C., BELITSKY, G.A., RONAI, Z.: High frequency of K-ras mutations in normal appearing lung tissues and sputum of patients with lung cancer. Int. J. Cancer, 63, 1995, 810-814.
55. YOAKUM, G.H., LECHNER, J.F., GABRIELSON, E.W., KORBA, B.E., MALAN-SHIBLEY, L., WILLEY, J.C., VALERIO, M.G., SHAMSUDDIN, A.M., TRUMP, B.F., HARRIS, C.C.: Transformation of human bronchial epithelial cells transfected by Harvey ras oncogene. Science, 227, 1985, 1174-1179.
56. YOU, M., CANDRIAN, U., MARONPOT, R.R., STONER, G.D., ANDERSON, M.W.: Activation of the Ki-ras protooncogene in spontaneously occurring and chemically induced lung tumors of the strain A mouse. Proc. Natl. Acad. Sci. USA, 86, 1989, 3070-3074.
57. ZHANG, Y., MUKHOPADHYAY, T., DONEHOWER, L.A., GEORGES, R.N., ROTH, J.A.: Retroviral vector-mediated transduction of K-ras antisense RNA into human lung cancer cells inhibits expression of the malignant phenotype. Hum. Gene Ther., 4, 1993, 451-460.